Alumni raised $1.45B in 2022 - Download Free Report Now

BioRelix

Antibiotics focused on Riboswitches (RNA drug targets) to treat drug resistant fungal and bacterial pathogens.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioRelix plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About BioRelix

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With